Cited by 5,204Epilepsy research and treatmentPharmacological Effects and Toxicity StudiesDiet and metabolism studies

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Early Identification of Refractory Epilepsy

Open access

Kwan, Patrick, Brodie, Martin J.·2000·New England Journal of Medicine

DOI 10.1056/nejm200002033420503

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: More than 30 percent of patients with epilepsy have inadequate control of seizures with drug therapy, but why this happens and whether it can be predicted are unknown. We studied the response to antiepileptic drugs in patients with newly diagnosed epilepsy to identify factors associated with subsequent poor control of seizures. METHODS: We prospectively studied 525 patients (age, 9 to 93 years) who were given a diagnosis, treated, and followed up at a single center between 1984 and 1997. Epilepsy was classified as idiopathic (with a presumed genetic basis), symptomatic (resulting from a structural abnormality), or cryptogenic (resulting from an unknown underlying cause). Patients were considered to be seizure-free if they had not had any seizures for at least one year. RESULTS: Among the 525 patients, 333 (63 percent) remained seizure-free during antiepileptic-drug treatment or after treatment was stopped. The prevalence of persistent seizures was higher in patients with symptomatic or cryptogenic epilepsy than in those with idiopathic epilepsy (40 percent vs. 26 percent, P=0.004) and in patients who had had more than 20 seizures before starting treatment than in those who had had fewer (51 percent vs. 29 percent, P<0.001). The seizure-free rate was similar in patients who were treated with a single established drug (67 percent) and patients who were treated with a single new drug (69 percent). Among 470 previously untreated patients, 222 (47 percent) became seizure-free during treatment with their first antiepileptic drug and 67 (14 percent) became seizure-free during treatment with a second or third drug. In 12 patients (3 percent) epilepsy was controlled by treatment with two drugs. Among patients who had no response to the first drug, the percentage who subsequently became seizure-free was smaller (11 percent) when treatment failure was due to lack of efficacy than when it was due to intolerable side effects (41 percent) or an idiosyncratic reaction (55 percent). CONCLUSIONS: Patients who have many seizures before therapy or who have an inadequate response to initial treatment with antiepileptic drugs are likely to have refractory epilepsy.

Integrity signals

Registry

Crossref · 10.1056/nejm200002033420503

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Proposal for Revised Classification of Epilepsies and Epileptic Syndromes: Commission on Classification and Terminology of the International League Against Epilepsy
(1989) · Epilepsia · doi:10.1111/j.1528-1157.1989.tb05316.x · Cited by 5,347
Guidelines for Epidemiologic Studies on Epilepsy
(1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb00433.x · Cited by 1,360
Is the underlying cause of epilepsy a major prognostic factor for recurrence?
Semah, F., Picot, M., Adam, C., Broglin, D., Arzimanoglou, A. A., Bazin, B., Cavalcanti, D., & Baulac, M. (1998) · Neurology · doi:10.1212/wnl.51.5.1256 · Cited by 1,105
Surgery for Seizures
Engel, J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603073341008 · Cited by 880
Long-Term Prognosis of Seizures with Onset in Childhood
Sillanpää, M. L., Jalava, M., Kaleva, O., & Shinnar, S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806113382402 · Cited by 725
Remission of Seizures and Relapse in Patients with Epilepsy
Annegers, J. F., Hauser, W. A., & Elveback, L. R. (1979) · Epilepsia · doi:10.1111/j.1528-1157.1979.tb04857.x · Cited by 621
Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
Brodie, M. J., UK Lamotrigine/Carbamazepine Monotherapy Trial Group, Richens, A., & Yuen, A. W. C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90581-2 · Cited by 614
Self-citation
MDR1 Gene Expression in Brain of Patients with Medically Intractable Epilepsy
Tishler, D. M., Weinberg, K. I., Hinton, D. R., Barbaro, N. M., Annett, G., & Raffel, C. (1995) · Epilepsia · doi:10.1111/j.1528-1157.1995.tb01657.x · Cited by 529
Multidrug resistance: molecular mechanisms and clinical relevance
Ling, V. W. T. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051053 · Cited by 525
Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy
Brodie, M. J., Overstall, P. W., & Giorgi, L. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(99)00039-x · Cited by 462
Self-citation

Show all 39 references

Research works printed but not linked: 2

Dreifuss FE. Classification of epileptic seizures. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Vol. 1. Philadelphia: Lippincott-Raven, 1998:517-24.
Wolf P. International classification of the epilepsies. In: Engel J Jr, Pedley TA, eds. Epilepsy: a comprehensive textbook. Vol. 1. Philadelphia: Lippincott-Raven, 1998:773-7.

Sorted by citations

Items 701–800 of 1,005

Marketed New Antiepileptic Drugs: Are They Better Than Old-Generation Agents?
Perucca, E. (2002) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200202000-00013 · Cited by 65
Surgical treatment for extratemporal epilepsy
Cascino, G. D. (2004) · Current Treatment Options in Neurology · doi:10.1007/s11940-004-0017-4 · Cited by 65
Prospective validation of a machine learning model that uses provider notes to identify candidates for resective epilepsy surgery
Wissel, B. D., Greiner, H. M., Glauser, T. A., Holland‐Bouley, K. D., Mangano, F. T., Santel, D., Faist, R., Zhang, N., Pestian, J. P., Szczesniak, R. D., et al. (2020) · Epilepsia · doi:10.1111/epi.16398 · Cited by 61
Extended-release formulations: simplifying strategies in the management of antiepileptic drug therapy
Pellock, J. M., Smith, M. C., Cloyd, J. C., Uthman, B., & Wilder, B. J. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2004.01.009 · Cited by 64
Effect of dosage failed of first antiepileptic drug on subsequent outcome
Brodie, M. J., Barry, S., Bamagous, G. A., & Kwan, P. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03722.x · Cited by 64
Self-citation
Implications of genetic diagnostics in epilepsy surgery candidates: A single‐center cohort study
Sanders, M. W. C. B., Lemmens, C. M. C., Jansen, F. E., Brilstra, E. H., Koeleman, B. P. C., Braun, K. P. J., & (LWEC), T. D. C. E. S. P. (2019) · Epilepsia Open · doi:10.1002/epi4.12366 · Cited by 63
Relationship between hospital surgical volume, lobectomy rates, and adverse perioperative events at US epilepsy centers
Englot, D. J., Ouyang, D., Wang, D. D., Rolston, J. D., Garcia, P. A., & Chang, E. F. (2012) · Journal of neurosurgery · doi:10.3171/2012.9.jns12776 · Cited by 64
Idiopathic-generalized epilepsy shows profound white matter diffusion-tensor imaging alterations
Focke, N. K., Diederich, C., Helms, G., Nitsche, M. A., Lerche, H., & Paulus, W. (2013) · Human Brain Mapping · doi:10.1002/hbm.22405 · Cited by 64
American Clinical MEG Society (ACMEGS) Position Statement: The Value of Magnetoencephalography (MEG)/Magnetic Source Imaging (MSI) in Noninvasive Presurgical Evaluation of Patients With Medically Intractable Localization-related Epilepsy
Bagic, A. I., Funke, M. E., & Ebersole, J. S. (2009) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0b013e3181b49d50 · Cited by 64
Emerging drugs for epilepsy
Kwan, P., & Brodie, M. J. (2007) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.12.3.407 · Cited by 64
Self-citation
Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 — A ten-year overview
Willems, L. M., Richter, S., Watermann, N., Bauer, S., Klein, K. M., Reese, J., Schöffski, O., Hamer, H. M., Knake, S., Rosenow, F., et al. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.03.025 · Cited by 64
Overtreatment in epilepsy: adverse consequences and mechanisms
Perucca, E. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00182-1 · Cited by 64
Efficacy of vagus nerve stimulation for refractory epilepsy among patient subgroups: A re-analysis using the Engel classification
Wheeler, M., Herdt, V. D., Vonck, K. E. J., Gilbert, K. L., Manem, S., MacKenzie, T. A., Jobst, B. C., Roberts, D. W., Williamson, P. D., Roost, D. V., et al. (2011) · Seizure · doi:10.1016/j.seizure.2011.01.002 · Cited by 63
The costs of epilepsy in Australia
Foster, E., Chen, Z. Z., Zomer, E., Rychkova, M., Carney, P. W., O'Brien, T. J., Liew, D., Jackson, G. D., Kwan, P., & Ademi, Z. (2020) · Neurology · doi:10.1212/wnl.0000000000010862 · Cited by 63
Self-citation
Role of Astrocytic Inwardly Rectifying Potassium (Kir) 4.1 Channels in Epileptogenesis
Kinboshi, M., Ikeda, A., & Ohno, Y. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.626658 · Cited by 63
Ultra-high field magnetic resonance imaging in human epilepsy: A systematic review
van Lanen, R. H. G. J., Colon, A., Wiggins, C. J., Hoeberigs, M. C., Hoogland, G., Roebroeck, A. F., Ivanov, D., Poser, B. A., Rouhl, R. P. W., Hofman, P. A. M., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102602 · Cited by 63
EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy
Traub‐Weidinger, T., Arbizu, J., Barthel, H., Boellaard, R., Borgwardt, L., Brendel, M., Cecchin, D., Chassoux, F., Fraioli, F., Garibotto, V., et al. (2024) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-024-06656-3 · Cited by 63
“Approximately 30% , however, do not respond to two ASMs and are considered drug resistant [3–5].”
Background
Arachidonyl-2′-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model
Łuszczki, J. J., Czuczwar, P., Cioczek‐Czuczwar, A., & Czuczwar, S. J. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.07.037 · Cited by 63
Medical management of refractory epilepsy—Practical treatment with novel antiepileptic drugs
Ben‐Menachem, E. (2014) · Epilepsia · doi:10.1111/epi.12494 · Cited by 63
Studies on the anticonvulsant activity of 4-alkyl-1,2,4-triazole-3-thiones and their effect on GABAergic system
Plech, T., Kaproń, B., Łuszczki, J. J., Paneth, A., Siwek, A., Kołaczkowski, M., Żołnierek, M., & Nowak, G. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.034 · Cited by 63
Pharmacological outcomes in older people with newly diagnosed epilepsy
Stephen, L. J., Kelly, K., Mohanraj, R., & Brodie, M. J. (2006) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2005.11.007 · Cited by 63
Self-citation
Vagus Nerve Stimulation in the Treatment of Refractory Epilepsy
Milby, A. H., Halpern, C. H., & Baltuch, G. H. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.01.010 · Cited by 63
Severity of anxiety and depression are related to a higher perception of adverse effects of antiepileptic drugs
Gómez-Arias, B., Crail‐Meléndez, D., Zapata, R. L., & Martínez-Juárez, I. E. (2012) · Seizure · doi:10.1016/j.seizure.2012.06.003 · Cited by 63
Intractable epilepsy: A survey of patients and caregivers
Wheless, J. W. (2006) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2006.03.010 · Cited by 63
Response to placebo in clinical epilepsy trials—Old ideas and new insights
Goldenholz, D. M., & Goldenholz, S. R. (2016) · Epilepsy Research · doi:10.1016/j.eplepsyres.2016.02.002 · Cited by 63
Lamotrigine and levetiracetam exert a similar modulation of TMS‐evoked EEG potentials
Premoli, I., Biondi, A., Carlesso, S., Rivolta, D., & Richardson, M. P. (2016) · Epilepsia · doi:10.1111/epi.13599 · Cited by 63
Association of Levels of Specialized Care With Risk of Premature Mortality in Patients With Epilepsy
Lowerison, M. W., Josephson, C. B., Jetté, N., Sajobi, T. T., Patten, S. B., Williamson, T. S., Deardon, R., Barkema, H. W., & Wiebe, S. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.2268 · Cited by 63
The role of chronobiology in drug-resistance epilepsy: The potential use of a variability and chronotherapy-based individualized platform for improving the response to anti-seizure drugs
Potruch, A., Khoury, S. T., & Ilan, Y. (2020) · Seizure · doi:10.1016/j.seizure.2020.06.032 · Cited by 62
Factors Predictive of Outcome in Childhood Epilepsy
Oskoui, M., Webster, R., Zhang, X., & Shevell, M. I. (2005) · Journal of Child Neurology · doi:10.1177/08830738050200110701 · Cited by 63
Isobolographic profile of interactions between tiagabine and gabapentin: a preclinical study A,B
Łuszczki, J. J., & Czuczwar, S. J. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-004-0867-z · Cited by 63
How refractory is refractory epilepsy? Patterns of relapse and remission in people with refractory epilepsy
Neligan, A., Bell, G. S., Sander, J. W. A. S., & Shorvon, S. D. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.06.004 · Cited by 62
Antiepileptic drug treatment patterns and economic burden of commercially-insured patients with refractory epilepsy with partial onset seizures in the United States
Chen, S., Wu, N., Boulanger, L., & Sacco, P. (2012) · Journal of Medical Economics · doi:10.3111/13696998.2012.751918 · Cited by 62
The potential implication of SCN1A and CYP3A5 genetic variants on antiepileptic drug resistance among Egyptian epileptic children
Fotoh, W. M. M. A. E., Naby, S. A. A. E., Habib, M. S. E., ALrefai, A. A., & Kasemy, Z. A. A. (2016) · Seizure · doi:10.1016/j.seizure.2016.07.005 · Cited by 62
Global Health: Epilepsy
Ali, A. (2018) · Seminars in neurology · doi:10.1055/s-0038-1646947 · Cited by 56
The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study
Mitelpunkt, A., Kramer, U., Hausman‐Kedem, M., Fink, E. Z., Orbach, R., Chernuha, V., Fattal‐Valevski, A., Deutsch, L., Heffetz, D., & Sacks, H. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.07.007 · Cited by 67
Surgical Outcomes of Laser Interstitial Thermal Therapy for Temporal Lobe Epilepsy: Systematic Review and Meta-analysis.
Kerezoudis, P., Parisi, V., Marsh, R., Kaufman, T. J., Lehman, V., Worrell, G., Miller, K., & Gompel, J. V. (2020) · World Neurosurgery · doi:10.1016/j.wneu.2020.07.194 · Cited by 61
Efficacy and tolerability of antiseizure drugs
Hakami, T. M. (2021) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864211037430 · Cited by 67
Norwegian population‐based study of long‐term effects, safety, and predictors of response of vagus nerve stimulation treatment in drug‐resistant epilepsy: The NORPulse study
Kostov, K. H., Kostov, H., Larsson, P. G., Henning, O. J., Eckmann, C. A. C., Lossius, M. I., & Peltola, J. (2021) · Epilepsia · doi:10.1111/epi.17152 · Cited by 62
Manipulating the epileptic brain using stimulation: a review of experimental and clinical studies
Saillet, S., Langlois, M., Feddersen, B., Minotti, L., Vercueil, L., Chabardès, S., Olivier David, A., Depaulis, A., Deransart, C., & Kahane, P. (2009) · Epileptic Disorders · doi:10.1684/epd.2009.0255 · Cited by 62
A Novel Positron Emission Tomography Imaging Protocol Identifies Seizure-Induced Regional Overactivity of P-Glycoprotein at the Blood-Brain Barrier
Bankstahl, J. P., Bankstahl, M., Kuntner, C., Stanek, J., Wanek, T., Meier, M., Ding, X. Q., Müller, M., Langer, O., & Löscher, W. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6616-10.2011 · Cited by 62
Illness perceptions of health care workers in relation to epileptic and psychogenic nonepileptic seizures
Worsely, C., Whitehead, K., Kandler, R., & Reuber, M. (2011) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2011.01.029 · Cited by 62
Seizure remission and relapse in adults with intractable epilepsy: A cohort study
Choi, H., Heiman, G. A., Pandis, D., Cantero, J., Resor, S. R., Gilliam, F. G., & Hauser, W. A. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01601.x · Cited by 62
Old versus New: Why Do We Need New Antiepileptic Drugs?
Lee, S. K. (2014) · Journal of Epilepsy Research · doi:10.14581/jer.14010 · Cited by 62
Pluronic P85-coated poly(butylcyanoacrylate) nanoparticles overcome phenytoin resistance in P-glycoprotein overexpressing rats with lithium-pilocarpine-induced chronic temporal lobe epilepsy
Fang, Z., Chen, S., Qin, J., Chen, B., Ni, G., Chen, Z., Zhou, J., Li, Z., Ning, Y., Wu, C., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.021 · Cited by 64
Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Papadelis, C. L., Tamilia, E., Stufflebeam, S. M., Grant, P. E., Madsen, J. R., Pearl, P. L., & Tanaka, N. (2016) · Journal of Visualized Experiments · doi:10.3791/54883 · Cited by 62
Outcomes in newly diagnosed localization-related epilepsies
Mohanraj, R., & Brodie, M. J. (2005) · Seizure · doi:10.1016/j.seizure.2005.04.002 · Cited by 62
Self-citation
Pharmacodynamic and Pharmacokinetic Characterization of Interactions between Levetiracetam and Numerous Antiepileptic Drugs in the Mouse Maximal Electroshock Seizure Model: An Isobolographic Analysis
Łuszczki, J. J., Andres‐Mach, M., Czuczwar, P., Cioczek‐Czuczwar, A., Ratnaraj, N., Patsalos, P. N., & Czuczwar, S. J. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00364.x · Cited by 62
MRI compatible EEG electrode system for routine use in the epilepsy monitoring unit and intensive care unit
Mirsattari, S. M., Lee, D. H., Jones, D., Bihari, F., & Ives, J. R. (2004) · Clinical Neurophysiology · doi:10.1016/j.clinph.2004.04.011 · Cited by 62
Isobolographic and subthreshold methods in the detection of interactions between oxcarbazepine and conventional antiepileptics—a comparative study
Łuszczki, J. J., & Czuczwar, S. J. (2003) · Epilepsy Research · doi:10.1016/j.eplepsyres.2003.08.003 · Cited by 62
The Star Systems
Brodie, M. J., & Kwan, P. (2001) · CNS Drugs · doi:10.2165/00023210-200115010-00001 · Cited by 62
Self-citation
Perampanel in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus
Strzelczyk, A., Willems, L. M., Willig, S., Rosenow, F., & Bauer, S. (2015) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2015.1091303 · Cited by 61
In vivo screening and toxicity studies of indolinone incorporated thiosemicarbazone, thiazole and piperidinosulfonyl moieties as anticonvulsant agents
Fayed, E. A., Ragab, A., Eldin, R. R. E., Bayoumi, A. H., & Ammar, Y. A. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105300 · Cited by 62
Natural History Study of STXBP1-Developmental and Epileptic Encephalopathy Into Adulthood
Stamberger, H., Crosiers, D., Balagura, G., Bonardi, C. M., Basu, A. P., Cantalupo, G., Chiesa, V., Christensen, J., Bernardina, B. D., Ellis, C. A., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000200715 · Cited by 61
“Seizure freedom was defined as the period without seizures being at least 3 times longer than the longest interseizure interval in the preceding year.(33) Cognitive outcome was defined based on the level of adaptive functioning as proposed by theDiagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM…”
[ 18 F] Fluorodeoxyglucose–Positron-Emission Tomography and MR Imaging Coregistration for Presurgical Evaluation of Medically Refractory Epilepsy
Lee, K. K., & Salamon, N. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1637 · Cited by 61
Pharmacologically intractable epilepsy in children: diagnosis and preoperative evaluation
Go, C., & Snead, O. C. (2008) · Neurosurgical FOCUS · doi:10.3171/foc/2008/25/9/e2 · Cited by 61
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review
Nevitt, S. J., Marson, A. G., Weston, J., & Smith, C. T. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001911.pub3 · Cited by 61
The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy—an open-label, prospective, randomised controlled multicenter study
Rosenow, F., Schade‐Brittinger, C., Burchardi, N., Bauer, S., Klein, K. M., Weber, Y. G., Lerche, H., Evers, S., Kovac, S., Hallmeyer‐Elgner, S., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301999 · Cited by 61
Stereotactic laser ablation of the splenium for intractable epilepsy
Ho, A. L., Miller, K. J., Cartmell, S., Inoyama, K., Fisher, R. S., & Halpern, C. H. (2016) · Epilepsy & Behavior Case Reports · doi:10.1016/j.ebcr.2015.12.003 · Cited by 61
Vagus nerve stimulation therapy in partial epilepsy: a review
Panebianco, M., Zavanone, C., Dupont, S., Restivo, D. A., & Pavone, A. (2016) · Acta Neurologica Belgica · doi:10.1007/s13760-016-0616-3 · Cited by 61
The prevalence rates of medication adherence and factors influencing adherence to antiepileptic drugs in children with epilepsy: A systematic review and meta analysis
Yang, C., Hao, Z., Yu, D., Xu, Q., & Zhang, L. (2018) · Epilepsy Research · doi:10.1016/j.eplepsyres.2018.03.018 · Cited by 61
Automated EEG source imaging: A retrospective, blinded clinical validation study
Baroumand, A. G., van Mierlo, P., Strobbe, G., Pinborg, L. H., Fabricius, M. E., Rubboli, G., Leffers, A.-M., Uldall, P. V., Jespersen, B., Brennum, J., et al. (2018) · Clinical Neurophysiology · doi:10.1016/j.clinph.2018.09.015 · Cited by 61
A New Look at the Second-Generation Antiepileptic Drugs
LaRoche, S. M. (2007) · The Neurologist · doi:10.1097/01.nrl.0000256353.14257.7c · Cited by 61
Antiepileptic drug treatment before and after selective amygdalohippocampectomy
Wieser, H. G., & Häne, A. (2003) · Epilepsy Research · doi:10.1016/s0920-1211(03)00116-5 · Cited by 61
The Outcome of Children with Intractable Seizures: A 3‐ to 6‐Year Follow‐up of 67 Children Who Remained on the Ketogenic Diet Less Than One Year
Marsh, E. B., Freeman, J. M., Kossoff, E. H., Vining, E. P. G., Rubenstein, J. E., Pyzik, P. L., & Hemingway, C. A. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00439.x · Cited by 61
Vascular Abnormalities and the Role of Vascular Endothelial Growth Factor in the Epileptic Brain
Ogaki, A., Ikegaya, Y., & Koyama, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00020 · Cited by 62
Schaftoside Suppresses Pentylenetetrazol-Induced Seizures in Zebrafish via Suppressing Apoptosis, Modulating Inflammation, and Oxidative Stress
Dang, J., Paudel, Y. N., Yang, X., Ren, Q., Zhang, S., Ji, X., Liu, K., & Jin, M. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00314 · Cited by 60
Colloquium: Multiscale modeling of brain network organization
Presigny, C., & Fallani, F. D. V. (2022) · Reviews of Modern Physics · doi:10.1103/revmodphys.94.031002 · Cited by 66
Prevalence and Risk Factors for Pharmacoresistance in Children With Focal Cortical Dysplasia–Related Epilepsy
Cohen, N. T., Chang, P. L., You, X., Zhang, A., Havens, K. A., Oluigbo, C. O., Whitehead, M. T., Gholipour, T., & Gaillard, W. D. (2022) · Neurology · doi:10.1212/wnl.0000000000201033 · Cited by 60
“16 This is based largely on observational cohorts of low likelihood of seizure freedom after failure of 2 ASM trials.23 In adults, there is an 11.6% chance of seizure freedom after failure of 1 ASM and only 1%–4% chance of seizure freedom after failure of 2 ASMs.23,24 In children, there are reports of a 19% chance of…”
BackgroundInfluential
Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy
French, J. A., Porter, R. J., Perucca, E., Brodie, M. J., Rogawski, M. A., Pimstone, S. N., Aycardi, E., Harden, C. L., Qian, J., Luzon, C., et al. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.3542 · Cited by 60
Self-citation
Management of Refractory Epilepsy
Muñana, K. R. (2013) · Topics in companion animal medicine · doi:10.1053/j.tcam.2013.06.007 · Cited by 60
In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein
Zhang, C., Kwan, P., Zuo, Z., & Baum, L. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.04.008 · Cited by 60
Self-citation
Perceptions of epilepsy surgery: A systematic review and an explanatory model of decision-making
Dewar, S. R., & Pieters, H. C. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.12.027 · Cited by 60
Vagus Nerve Stimulation Therapy: Indications, Programing, and Outcomes
Yamamoto, T. (2015) · Neurologia medico-chirurgica · doi:10.2176/nmc.ra.2014-0405 · Cited by 60
SCN1A , SCN2A and SCN3A Gene Polymorphisms and Responsiveness to Antiepileptic Drugs: A Multicenter Cohort Study and Meta-Analysis
Haerian, B. S., Baum, L., Kwan, P., Tan, H. J., Raymond, A. A., & Mohamed, Z. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.104 · Cited by 60
Self-citation
Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review
Nevitt, S. J., Smith, C. T., Weston, J., & Marson, A. G. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001031.pub4 · Cited by 61
Stereotactic MRI‐guided laser interstitial thermal therapy for extratemporal lobe epilepsy
Gupta, K., Cabaniss, B. T., Kheder, A., Gedela, S., Koch, P. F., Hewitt, K. C., Alwaki, A., Rich, C. W., Ramesha, S., Hu, R., et al. (2020) · Epilepsia · doi:10.1111/epi.16614 · Cited by 60
Real-World Preliminary Experience With Responsive Neurostimulation in Pediatric Epilepsy: A Multicenter Retrospective Observational Study
Nagahama, Y., Zervos, T. M., Murata, K. K., Holman, L., Karsonovich, T. W., Parker, J. J., Chen, J., Phillips, H. W., Fajardo, M., Nariai, H., et al. (2021) · Neurosurgery · doi:10.1093/neuros/nyab343 · Cited by 60
Modern antiepileptic drugs: guidelines and beyond
Hitiris, N., & Brodie, M. J. (2006) · Current Opinion in Neurology · doi:10.1097/01.wco.0000218235.67840.82 · Cited by 60
Self-citation
Progress in epilepsy: reducing the treatment gap and the promise of biomarkers
Engel, J. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282f4edc3 · Cited by 59
Long-term outcomes of mesial temporal laser interstitial thermal therapy for drug-resistant epilepsy and subsequent surgery for seizure recurrence: a multi-centre cohort study
Youngerman, B. E., Banu, M. A., Khan, F. A., McKhann, G. M., Schevon, C. A., Jagid, J. R., Cajigas, I., Theodotou, C. B., Ko, A. L., Buckley, R. T., et al. (2023) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2022-330979 · Cited by 59
Antiepileptic drugs, hyperhomocysteinemia and B-vitamins supplementation in patients with epilepsy
Belcastro, V., & Striano, P. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.07.003 · Cited by 60
Neuromodulation in the Treatment of Epilepsy
Nune, G. C., DeGiorgio, C. M., & Heck, C. N. (2015) · Current Treatment Options in Neurology · doi:10.1007/s11940-015-0375-0 · Cited by 59
Brivaracetam: a novel antiepileptic drug for focal-onset seizures
Stephen, L. J., & Brodie, M. J. (2017) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285617742081 · Cited by 59
Self-citation
Glycyrrhizin, an HMGB1 inhibitor, exhibits neuroprotective effects in rats after lithium-pilocarpine-induced status epilepticus
Li, Y., Wang, L., Zhang, B., Gao, F., & Yang, C.-M. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13040 · Cited by 59
Seletracetam (UCB 44212)
Bennett, B. A., Matagne, A., Michel, P., Leonard, M., Cornet, M., Meeus, M.-A., & Toublanc, N. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2006.11.014 · Cited by 59
The potential of pharmacogenetics in the treatment of epilepsy
Depondt, C. (2006) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2005.11.009 · Cited by 59
A Self-Interpretable Deep Learning Model for Seizure Prediction Using a Multi-Scale Prototypical Part Network
Gao, Y., Liu, A., Wang, L., Qian, R., & Chen, X. (2023) · IEEE Transactions on Neural Systems and Rehabilitation Engineering · doi:10.1109/tnsre.2023.3260845 · Cited by 61
Epilepsy and Epileptic Syndrome
Ono, T., & Galanopoulou, A. S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0653-2_8 · Cited by 62
Parietal lobe epilepsy: the great imitator among focal epilepsies
Ristić, A. J., Alexopoulos, A. V., So, N. K., Wong, C., & Najm, I. (2012) · Epileptic Disorders · doi:10.1684/epd.2012.0484 · Cited by 58
High seizure frequency prior to antiepileptic treatment is a predictor of pharmacoresistant epilepsy in a rat model of temporal lobe epilepsy
Löscher, W., & Brandt, C. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02183.x · Cited by 58
Patient perceptions and barriers to epilepsy surgery: Evaluation in a large health region
Hrazdil, C. T., Roberts, J. I., Wiebe, S., Sauro, K. M., Vautour, M., Hanson, A., Murphy, W. F., Pillay, N., Federico, P., & Jetté, N. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.03.013 · Cited by 58
The effects of duration of intractable epilepsy on memory function
Kent, G. P., Schefft, B. K., Howe, S. R., Szaflarski, J. P., Yeh, H., & Privitera, M. (2006) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2006.07.005 · Cited by 58
High-resolution functional MRI at 3T in healthy and epilepsy subjects: hippocampal activation with picture encoding task
Szaflarski, J. P., Holland, S. K., Schmithorst, V. J., Dunn, R. S., & Privitera, M. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2004.01.002 · Cited by 58
Disease Progression and Treatment Response of Idiopathic Epilepsy in Australian Shepherd Dogs
Weißl, J., Hülsmeyer, V., Brauer, C., Tipold, A., Koskinen, L. L. E., Kyöstilä, K., Lohi, H., Sauter‐Louis, C., Wolf, M., & Fischer, A. (2011) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2011.00853.x · Cited by 58
Reasons for uncontrolled seizures in adults; the impact of pseudointractability
Asadi‐Pooya, A. A., Emami, M., Ashjazadeh, N., Nikseresht, A., Shariat, A., Petramfar, P., Yousefipour, G., Borhani‐Haghighi, A., Izadi, S., & Jaberi, A. R. (2013) · Seizure · doi:10.1016/j.seizure.2013.01.010 · Cited by 58
Tonic GABAA Receptors as Potential Target for the Treatment of Temporal Lobe Epilepsy
Schipper, S., Aalbers, M. W., Rijkers, K., Swijsen, A., Rigo, J., Hoogland, G., & Vles, J. S. H. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9423-8 · Cited by 59
Seizure pathways: A model-based investigation
Karoly, P. J., Kuhlmann, L., Soudry, D., Grayden, D. B., Cook, M. J., & Freestone, D. R. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006403 · Cited by 61
Comparison and Selection of Current Implantable Anti-Epileptic Devices
Wong, S., Mani, R., & Danish, S. F. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00727-2 · Cited by 59
Trends in the use of automated algorithms for the detection of high‐frequency oscillations associated with human epilepsy
Sindhu, K. R., Staba, R. J., & Lopour, B. A. (2020) · Epilepsia · doi:10.1111/epi.16622 · Cited by 58
Predicting drug resistance in adult patients with generalized epilepsy: A case–control study
Voll, A., Hernández‐Ronquillo, L., Buckley, S., & Téllez‐Zenteno, J. F. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.09.027 · Cited by 57

Authors: Kwan, P., & Brodie, M. J.
Affiliations: Western Infirmary (GB)
ORCID: Kwan, Patrick
Brodie, Martin J.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2000-02-03
Volume: 342
Issue: 5
Pages: 314-319
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm200002033420503
OpenAlex: W1974809694
Cited by: 5,204
References: 39
Citations by year: 2026: 225 · 2025: 241 · 2024: 259 · 2023: 275 · 2022: 269 · 2021: 328 · 2020: 348 · 2019: 253 · 2018: 270 · 2017: 228 · 2016: 249 · 2015: 230 · 2014: 205 · 2013: 233 · 2012: 248
FWCI: 55.69
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
CRC Press eBooks (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
Keywords: drug-resistant epilepsy, antiepileptic drugs, seizure control, newly diagnosed epilepsy, idiopathic epilepsy, symptomatic epilepsy, cryptogenic epilepsy, seizure frequency, predictors of treatment failure, adverse drug reactions, polypharmacy
MeSH terms: Adolescent, Adult, Aged, Aged, 80 and over, Anticonvulsants, Child, Epilepsy, Female, Humans, Male, Middle Aged, Prospective Studies, Remission Induction, Treatment Failure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Early Identification of Refractory Epilepsy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks